Intas low-balls Mallinckrodt unit bid to $1bn on legal fears

Last year, media reports mentioned that Intas had emerged as a strong contender to acquire Mallinckrodt unit in a deal estimated between $1.5-2 billion.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news